Search research articles
Contact Us
Filters
Showing results (1-10 of 19) with videos related to
Page
of 2
Sort By:
Journal of Occupational and Environmental Medicine
|
January 8, 2015
Work productivity loss with depression, diagnosed and undiagnosed, among workers in an Internet-based survey conducted in Japan
Yuko Asami, Amir Goren, Yasuyuki Okumura
Brain and Nerve = Shinkei Kenkyu No Shinpo
|
June 15, 2021
[Studies on Monoamine Transporter Occupancy of Antidepressants using PET: Focusing on SERT and NET]
Satoshi Matsuyama, Ryosuke Arakawa, Yuko Asami
Drugs - Real World Outcomes
|
March 22, 2021
Antidyslipidemic Drug Prescriptions and Lipid Control Status After Unfavorable Annual Health Checkup Results: A Retrospective Cohort Study Using a Health Insurance Database
Kazutaka Nozawa, Shingo Higa, Yoichi Ii, et al.
International Journal of Psychiatry in Clinical Practice
|
April 22, 2017
A unique database for gathering data from a mobile app and medical prescription software: a useful data source to collect and analyse patient-reported outcomes of depression and anxiety symptoms
Yoshinori Watanabe, Yoko Hirano, Yuko Asami, et al.
BMJ Open
|
November 10, 2022
Physician consultation rates and characteristics among workers with chronic pain or headache who participated in a behavioural change program: a retrospective database analysis using real-world healthcare data
Kazutaka Nozawa, Satoshi Matsuyama, Shingo Higa, et al.
Molecular Vision
|
May 2, 2008
The function of filensin and phakinin in lens transparency
Mikako Oka, Hiroaki Kudo, Norio Sugama, et al.
Neuropsychiatric Disease and Treatment
|
May 31, 2018
Factors impacting the efficacy of venlafaxine extended release 75-225 mg/day in patients with major depressive disorder: exploratory post hoc subgroup analyses of a randomized, double-blind, placebo-controlled study in Japan
Yoshinori Watanabe, Yuko Asami, Yoko Hirano, et al.
Journal of Affective Disorders
|
April 2, 2017
Restoring function in major depressive disorder: A systematic review
David V Sheehan, Kazuyuki Nakagome, Yuko Asami, et al.
Current Medical Research and Opinion
|
November 1, 2016
A meta-analysis of the efficacy of venlafaxine extended release 75-225 mg/day for the treatment of major depressive disorder
Michael Thase, Yuko Asami, Dalia Wajsbrot, et al.
Value in Health Regional Issues
|
February 24, 2018
Possibility of Database Research as a Means of Pharmacovigilance in Japan Based on a Comparison with Sertraline Postmarketing Surveillance
Yoko Hirano, Yuko Asami, Kazuhiko Kuribayashi, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 19) with videos related to
Sort By:
Page
of 2
Journal of Occupational and Environmental Medicine
|
January 8, 2015
Work productivity loss with depression, diagnosed and undiagnosed, among workers in an Internet-based survey conducted in Japan
Yuko Asami, Amir Goren, Yasuyuki Okumura
Brain and Nerve = Shinkei Kenkyu No Shinpo
|
June 15, 2021
[Studies on Monoamine Transporter Occupancy of Antidepressants using PET: Focusing on SERT and NET]
Satoshi Matsuyama, Ryosuke Arakawa, Yuko Asami
Drugs - Real World Outcomes
|
March 22, 2021
Antidyslipidemic Drug Prescriptions and Lipid Control Status After Unfavorable Annual Health Checkup Results: A Retrospective Cohort Study Using a Health Insurance Database
Kazutaka Nozawa, Shingo Higa, Yoichi Ii, et al.
International Journal of Psychiatry in Clinical Practice
|
April 22, 2017
A unique database for gathering data from a mobile app and medical prescription software: a useful data source to collect and analyse patient-reported outcomes of depression and anxiety symptoms
Yoshinori Watanabe, Yoko Hirano, Yuko Asami, et al.
BMJ Open
|
November 10, 2022
Physician consultation rates and characteristics among workers with chronic pain or headache who participated in a behavioural change program: a retrospective database analysis using real-world healthcare data
Kazutaka Nozawa, Satoshi Matsuyama, Shingo Higa, et al.
Molecular Vision
|
May 2, 2008
The function of filensin and phakinin in lens transparency
Mikako Oka, Hiroaki Kudo, Norio Sugama, et al.
Neuropsychiatric Disease and Treatment
|
May 31, 2018
Factors impacting the efficacy of venlafaxine extended release 75-225 mg/day in patients with major depressive disorder: exploratory post hoc subgroup analyses of a randomized, double-blind, placebo-controlled study in Japan
Yoshinori Watanabe, Yuko Asami, Yoko Hirano, et al.
Journal of Affective Disorders
|
April 2, 2017
Restoring function in major depressive disorder: A systematic review
David V Sheehan, Kazuyuki Nakagome, Yuko Asami, et al.
Current Medical Research and Opinion
|
November 1, 2016
A meta-analysis of the efficacy of venlafaxine extended release 75-225 mg/day for the treatment of major depressive disorder
Michael Thase, Yuko Asami, Dalia Wajsbrot, et al.
Value in Health Regional Issues
|
February 24, 2018
Possibility of Database Research as a Means of Pharmacovigilance in Japan Based on a Comparison with Sertraline Postmarketing Surveillance
Yoko Hirano, Yuko Asami, Kazuhiko Kuribayashi, et al.
Page
of 2